upgrade
upgrade

๐Ÿ”ฌBiological Chemistry I

Types of Enzyme Inhibition

Study smarter with Fiveable

Get study guides, practice questions, and cheatsheets for all your subjects. Join 500,000+ students with a 96% pass rate.

Get Started

Why This Matters

Enzyme inhibition isn't just a biochemistry concept to memorizeโ€”it's the foundation for understanding how drugs work, how metabolic pathways are regulated, and how cells fine-tune their chemistry in real time. When you're tested on this material, you're being asked to demonstrate that you understand kinetic parameters, binding mechanisms, and regulatory logic. The differences between inhibition types show up constantly in exam questions, particularly when you need to interpret Lineweaver-Burk plots or predict how changing substrate concentration affects reaction velocity.

Here's the key insight: each inhibition type tells a story about where the inhibitor binds, when it binds (to free enzyme, ES complex, or both), and what happens to VmaxV_{max} and KmK_m as a result. Don't just memorize that competitive inhibition increases KmK_mโ€”understand why it does (the inhibitor is blocking the active site, so you need more substrate to outcompete it). Master the mechanism, and the kinetic changes follow logically.


Reversible Inhibition at the Active Site

These inhibitors compete directly with substrate for access to the enzyme's active site. Because binding is reversible and mutually exclusive with substrate, increasing substrate concentration can overcome the inhibition.

Competitive Inhibition

  • Inhibitor binds the active siteโ€”structurally resembles the substrate and directly blocks substrate access to the enzyme
  • VmaxV_{max} unchanged, KmK_m increasesโ€”you can still reach maximum velocity, but you need more substrate to get there (apparent affinity decreases)
  • Overcome by excess substrateโ€”this is the hallmark feature; flood the system with substrate and you outcompete the inhibitor

Reversible Inhibition Away from the Active Site

These inhibitors bind to sites other than the active site, causing conformational changes or blocking catalysis without directly competing for substrate binding. The key distinction is whether the inhibitor prefers free enzyme, ES complex, or both equally.

Non-Competitive Inhibition

  • Binds an allosteric site with equal affinity for E and ESโ€”substrate can still bind, but the enzyme-inhibitor complex is catalytically inactive or impaired
  • VmaxV_{max} decreases, KmK_m unchangedโ€”fewer functional enzyme molecules means lower maximum velocity, but substrate binding affinity isn't affected
  • Cannot be overcome by adding substrateโ€”since the inhibitor doesn't compete for the active site, more substrate won't help

Uncompetitive Inhibition

  • Binds only to the ES complexโ€”the inhibitor has no affinity for free enzyme, only for the enzyme-substrate complex
  • Both VmaxV_{max} and KmK_m decreaseโ€”traps ES complex, effectively removing it from the reaction; the apparent KmK_m drops because substrate binding is enhanced (but unproductive)
  • Common in multi-substrate reactionsโ€”look for this pattern when enzymes have ordered binding mechanisms

Mixed Inhibition

  • Binds both E and ES, but with different affinitiesโ€”this creates a spectrum between competitive and non-competitive behavior
  • VmaxV_{max} decreases; KmK_m can increase or decreaseโ€”if the inhibitor prefers free enzyme, KmK_m increases; if it prefers ES complex, KmK_m decreases
  • Most "non-competitive" inhibitors are actually mixedโ€”true non-competitive inhibition (equal affinity for E and ES) is relatively rare in nature

Compare: Competitive vs. Non-Competitive Inhibitionโ€”both are reversible, but competitive inhibitors can be overcome with excess substrate while non-competitive cannot. On a Lineweaver-Burk plot, competitive inhibition changes the x-intercept (KmK_m) while non-competitive changes the y-intercept (VmaxV_{max}). If an FRQ gives you kinetic data, check which parameter changed to identify the inhibition type.

Compare: Uncompetitive vs. Mixed Inhibitionโ€”both affect VmaxV_{max} and KmK_m, but uncompetitive only binds ES (both parameters decrease proportionally, giving parallel lines on Lineweaver-Burk), while mixed binds both E and ES with different affinities (lines intersect off-axis).


Irreversible Inhibition

Unlike reversible inhibitors that establish equilibrium, irreversible inhibitors permanently disable enzymes. Covalent bond formation means the enzyme molecule is lost from the active pool entirely.

Irreversible Inhibition

  • Forms covalent bonds with the enzymeโ€”typically modifies active site residues essential for catalysis (often serine, cysteine, or histidine)
  • VmaxV_{max} decreases progressivelyโ€”active enzyme concentration drops over time; effect is time-dependent and cumulative
  • Cannot be reversed by dilution or substrateโ€”the enzyme is permanently inactivated; cell must synthesize new enzyme to recover activity

Compare: Irreversible vs. Non-Competitive Inhibitionโ€”both decrease VmaxV_{max} without affecting substrate binding, but irreversible inhibition is permanent and time-dependent. Aspirin (irreversibly acetylates COX) vs. a reversible non-competitive inhibitor: one dose of aspirin affects platelets for their entire lifespan because platelets can't make new enzyme.


Regulatory Inhibition Mechanisms

These inhibition patterns serve important physiological roles in controlling metabolic flux. Cells use these mechanisms to respond to changing conditions and maintain homeostasis.

Allosteric Inhibition

  • Binding at regulatory sites causes conformational changeโ€”the enzyme shifts to a lower-activity state (T-state in concerted models)
  • Often produces sigmoidal kineticsโ€”cooperative binding means the enzyme doesn't follow simple Michaelis-Menten behavior; look for S-shaped curves
  • Critical for feedback regulationโ€”end products of metabolic pathways often inhibit early enzymes allosterically, preventing overproduction

Substrate Inhibition

  • Excess substrate decreases reaction rateโ€”at high concentrations, substrate can bind nonproductively or form dead-end complexes
  • Creates a bell-shaped velocity curveโ€”rate increases with substrate initially, then decreases at very high concentrations
  • Physiologically important safety mechanismโ€”prevents runaway reactions and helps maintain steady-state metabolite levels

Compare: Allosteric Inhibition vs. Substrate Inhibitionโ€”both represent regulatory mechanisms, but allosteric inhibition involves a separate molecule binding at a regulatory site, while substrate inhibition involves the substrate itself at high concentrations. Allosteric regulation is typically the cell's intentional control mechanism; substrate inhibition is often an intrinsic kinetic property.


Quick Reference Table

ConceptBest Examples
Active site bindingCompetitive inhibition
Allosteric site bindingNon-competitive, mixed, allosteric inhibition
ES complex onlyUncompetitive inhibition
VmaxV_{max} unchangedCompetitive inhibition
KmK_m unchangedNon-competitive inhibition
Both parameters decreaseUncompetitive inhibition
Covalent modificationIrreversible inhibition
Sigmoidal kineticsAllosteric inhibition
High [S] causes inhibitionSubstrate inhibition

Self-Check Questions

  1. You're analyzing a Lineweaver-Burk plot and notice that adding an inhibitor increases the slope but doesn't change the y-intercept. What type of inhibition is this, and what happened to KmK_m and VmaxV_{max}?

  2. Which two inhibition types both decrease VmaxV_{max} while leaving KmK_m unchanged? What distinguishes them mechanistically?

  3. A pharmaceutical company wants to design a drug that can be overcome by the body's natural substrate if concentrations rise. Which inhibition type should they target, and why?

  4. Compare uncompetitive and mixed inhibition: both affect KmK_m, but in what direction does KmK_m change for each, and what does this tell you about where the inhibitor binds?

  5. An enzyme shows normal Michaelis-Menten kinetics at low substrate concentrations but decreased velocity at very high substrate concentrations. What type of inhibition is occurring, and how would you distinguish this from allosteric inhibition on a kinetic plot?